News
Novo Nordisk ( NVO 1.82%) stock jumped 3% through 10:55 a.m. Tuesday on some potentially positive news in the GLP-1 weight ...
On a weekday morning in Dublin, a group of patients walked into a weight-loss clinic hoping to shed pounds. What they didn’t expect was to also lose their taste for alcohol. A new study has found that ...
Respondents see the glucagon-like peptide 1 (GLP-1) drugs as a major advance. They also have concerns about whether insurers ...
43m
Money Talks News on MSNWeight Loss Wonder Drugs: Which States Use Them Most?Spike Lee Says Denzel Washington Deserved Oscar for ‘Malcolm X' Over Al Pacino: ‘It's Like Basketball, Where the Ref Blows a ...
While medications like Wegovy promise quick results, many people still prefer a drug-free path to shedding pounds. Science ...
Struggling to find weight-loss drugs like Ozempic? Dr. Scourboutakos has 8 diet hacks that mimic the effects of GLP-1 meds for free. Turns out, tweaking your meals can help you shed pounds and prevent ...
Explore Viking's innovative GLP-1/GIP & THR-β therapies, with strong Phase 2/3 results, targeting major markets with ...
Lehigh Valley health experts discuss obesity, energy management, Medicaid changes, and GLP-1 drug trends at LVBCH’s 45th ...
Using Ozempic for weight loss is highly debatable. It is an anti-diabetes prescription drug used off-label for weight loss ...
Glucagon-like peptide-1 receptor agonists are tied to a reduction in alcohol intake in patients being treated for obesity.
Skye will provide funding for the development activities of Arecor with the option to licence rights to nimacimab’s new ...
Patients with diabetes mellitus who use GLP-1 RAs have an increased risk for acute and chronic pancreatitis, according to a study presented at DDW 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results